BS EN ISO 20387:2020+A11:2024 Biotechnology. Biobanking. General requirements for biobanking

Standard Number: BS EN ISO 20387:2020+A11:2024

Pages: 50

Released: 2024-07-26

ISBN: 978 0 539 32670 3

Name: Biotechnology. Biobanking. General requirements for biobanking

Status: Standard

Overview

The BS EN ISO 20387:2020+A11:2024 standard is a comprehensive guide that sets forth the general requirements for biobanking in the field of biotechnology. This standard is essential for organizations involved in the collection, storage, and distribution of biological materials, ensuring that they adhere to the highest quality and safety standards.

Key Features

• Comprehensive Coverage: Spanning 50 pages, this standard provides detailed guidelines and requirements for biobanking practices.
• Up-to-Date Information: Released on 2024-07-26, this standard includes the latest advancements and updates in the field of biotechnology and biobanking.
• International Recognition: As an ISO standard, it is recognized and respected globally, making it a valuable resource for international collaborations and projects.
• Quality Assurance: Ensures that biobanking practices meet the highest quality and safety standards, protecting the integrity of biological materials.
• ISBN: 978 0 539 32670 3, ensuring easy reference and cataloging.

Why Choose BS EN ISO 20387:2020+A11:2024?

Biobanking is a critical component of modern biotechnology, playing a vital role in research, development, and clinical applications. The BS EN ISO 20387:2020+A11:2024 standard provides a robust framework for biobanking operations, ensuring that biological materials are handled with the utmost care and precision. By adhering to this standard, organizations can:

• Enhance Credibility: Demonstrate their commitment to quality and safety, gaining the trust of stakeholders and collaborators.
• Ensure Compliance: Meet regulatory requirements and industry best practices, avoiding potential legal and operational issues.
• Improve Efficiency: Streamline biobanking processes, reducing errors and enhancing the overall efficiency of operations.
• Facilitate Research: Provide high-quality biological materials that are essential for cutting-edge research and development.

Who Should Use This Standard?

The BS EN ISO 20387:2020+A11:2024 standard is designed for a wide range of stakeholders in the biotechnology and biobanking sectors, including:

• Biobanks: Organizations that collect, store, and distribute biological materials for research and clinical purposes.
• Research Institutions: Universities, laboratories, and research centers that rely on high-quality biological samples for their work.
• Healthcare Providers: Hospitals and clinics that use biobanked materials for diagnostic and therapeutic purposes.
• Regulatory Bodies: Agencies responsible for overseeing biobanking practices and ensuring compliance with industry standards.
• Biotechnology Companies: Firms involved in the development of biotechnological products and services.

Detailed Content

The BS EN ISO 20387:2020+A11:2024 standard covers a wide range of topics related to biobanking, including:

• General Requirements: Fundamental principles and guidelines for biobanking operations.
• Quality Management: Strategies for maintaining the quality and integrity of biological materials.
• Operational Procedures: Detailed protocols for the collection, storage, and distribution of biological samples.
• Safety and Compliance: Measures to ensure the safety of personnel and compliance with regulatory requirements.
• Documentation and Record-Keeping: Best practices for maintaining accurate and comprehensive records.

Benefits of Compliance

Adhering to the BS EN ISO 20387:2020+A11:2024 standard offers numerous benefits, including:

• Enhanced Reputation: Organizations that comply with this standard are recognized for their commitment to quality and safety.
• Increased Funding Opportunities: Compliance with international standards can attract funding from government agencies and private investors.
• Improved Collaboration: Facilitates partnerships with other organizations and institutions that value high-quality biobanking practices.
• Risk Mitigation: Reduces the risk of errors, contamination, and other issues that can compromise the integrity of biological materials.
• Regulatory Compliance: Ensures that biobanking practices meet all relevant regulatory requirements, avoiding potential legal issues.

Conclusion

The BS EN ISO 20387:2020+A11:2024 standard is an indispensable resource for anyone involved in biobanking and biotechnology. By providing a comprehensive framework for biobanking operations, this standard ensures that biological materials are handled with the highest levels of quality and safety. Whether you are a biobank, research institution, healthcare provider, regulatory body, or biotechnology company, adhering to this standard will enhance your credibility, improve your operations, and facilitate groundbreaking research and development.

BS EN ISO 20387:2020+A11:2024

This standard BS EN ISO 20387:2020+A11:2024 Biotechnology. Biobanking. General requirements for biobanking is classified in these ICS categories:

• 07.080 Biology. Botany. Zoology